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Today (2016), http://dx.doi.org/10.1016/j.artBackground: Enhanced recovery after surgery protocols for total joint replacements (TJRs) emphasize
early discharge, yet the impact on readmissions is not well documented. We evaluate the impact of a
one-day length of stay (LOS) discharge protocol on readmissions.
Methods: Weconducted a retrospective reviewof all primary TJRs (hip and knee) fromApril 2014 toMarch
2015. Patients who had adequate support to be discharged home were categorized into 2 groups, 1-day
(n ¼ 174) vs 2-day (n ¼ 285) LOS groups. Patients discharged to rehabilitation were excluded (n ¼ 196).
Results: Patients in the 1 day group were more likely to be younger (61.7 vs 64.8 years, P < .001), be male
(56.3% vs 40.4%, P ¼ .001), and have a lower body mass index (30.0 vs 31.4 kg/m2, P ¼ .012). One-day LOS
patients had shorter surgical times (79.7 vs 85.6 minutes, P ¼ .001) and more likely had spinal anesthesia
(46.0% vs 31.2%, P ¼ .001). The overall 30-day all-cause (2.3% vs 2.5%, P ¼ .591) and 90-day wound-related
(1.1% vs 1.1%, P ¼ .617) readmission rates were equivalent between groups.
Conclusions: Early discharge does not increase readmissions and may help attenuate costs associated
with TJRs. Further reﬁnement of protocols may allow for more patients to be safely discharged on
postoperative day 1.
Copyright © 2016 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Enhanced recovery after surgery (ERAS) programs expedite
postoperative recovery, support an early discharge, and decrease
postoperative complications by promoting a multidisciplinary
approach to patient care [1]. Originally developed for colon surgery,
ERAS pathways are being adopted across a range of surgical spe-
cialties [2e4]. Developed using evidence-based medicine, ERAS
emphasizes a reduction in postoperative morbidity with strategies
targeting anesthesia, analgesia, ﬂuid management, nutrition, and
postoperative ambulation [1]. Speciﬁcally for total joint re-
placements (TJRs), protocols include preoperative patient educa-
tion and preparation, regional anesthesia, multimodal nonopioid
pain management, aggressive postoperative ﬂuid administration,
and early mobilization [5e7].closed potential or pertinent
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there were 1.1 million TJRs performed in the United States in 2012,
costing US $18.75 billion [8]. By 2030, the demand for TJRs is pro-
jected to increase by 174% for primary total hip arthroplasties and
673% for primary total knee arthroplasties [9]. With two-thirds of
all TJRs in the United States being performed on Medicare beneﬁ-
ciaries, these procedures represent a ﬁnancial burden to the Cen-
ters for Medicare & Medicaid Services (CMS) [10,11]. Efforts to
contain rising costs led to the creation of a bundled payments
reimbursement model, which rewards hospitals and surgeons that
can control costs. An important way to decrease costs is to decrease
hospital length of stay (LOS).
Early concerns have been raised that decreasing hospital stay
may result in an increase in hospital readmissions; however,
studies demonstrate that ERAS programs shorten LOS without
increasing complications or readmissions [12e18]. In 2014, CMS
updated its Readmissions Reduction Program to improve patient
outcomes after TJRs [10]. These TJR-speciﬁc qualitymeasures deﬁne
7-day, 30-day, and 90-day causes for readmissions [19]. Hospitals
now incur a ﬁnancial penalty for complications and readmissions
associated with TJRs.
Rapid recovery and shorter lengths of stay have become an
early measure of success after TJRs for both patients and hospitals.an Association of Hip and Knee Surgeons. This is an open access article under the CC
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being directed at updating ERAS pathways to further shorten
hospital stay, without adversely impacting patient outcomes
[20e22]. The purpose of this study was to evaluate our read-
missions rate after updating our institution’s ERAS program to
promote a 1-day LOS discharge protocol. The primary end point of
this study was to quantify the overall all-cause 30-day read-
missions rate. Secondary end points were to identify variables
associated with a shorter LOS.
Material and methods
All TJRs at our institution were performed under our ERAS
program. This includes preoperative, intraoperative, and post-
operative protocols for care delivery. Preoperative measures were
patient education, physical therapy, and medical evaluations. Pa-
tient education involved educational programs overviewing daily
activities after surgery, identifying a speciﬁc care companion
“Coach” at home, and discussing expectations. Preoperative phys-
ical therapy aimed to strengthen the upper and lower extremities.
All patients had a medical evaluation within 30 days of surgery.
Perioperative protocols included regional anesthesia, multimodal
pain management, aggressive intraoperative ﬂuid management,
tranexamic acid utilization, anticoagulation prophylaxis, and day of
surgery ambulation. Table 1 summarizes our pharmacological
protocol. Standard Surgical Care Improvement Guidelines for
perioperative antibiotics was followed. Pharmacologic (Aspirin 325
mg bid or Coumadin INR 1.8-2.4) and mechanical postoperative
deep vein thrombosis prophylaxis was maintained in all patients.
Oxycodone (5 mg increments as needed) was prescribed for pain
unresponsive to nonopioid analgesics.
On April 1, 2014, our ERAS programwas updated to promote an
earlier (1 day LOS) discharge protocol. Speciﬁcally, patient edu-
cation was updated to set expectations for discharge.Table 1
Enhanced recovery after surgery pharmacological protocol.
Preoperative pain management (single dose within 2 h of incision)
Acetaminophen 975 mg PO
Lyrica 50 mg PO
Protonix 40 mg PO
Oxycontin 10 mg PO
Scopolamine patcha
Celebrex 200 mg POb
Tranexamic acid (TXA)
Total knee replacement
Preincision 10 mg/kg, maximum dose 1000 mg
3 h after incision 10 mg/kg, maximum dose 1000 mg
Total hip replacement
Preincision 10 mg/kg, maximum dose 1000 mg
Periarticular injection
Morphine 5 mg
Toradol 15 mga
Ropivicaine 0.5% 30 cc
Epinephrine 1/1000 0.3 cc
Saline 30 cc
Postoperative pain management
Total knee replacement
Acetaminophen 975 mg PO q 4 as needed
Lyrica 50 mg PO bid  14 d
Celebrex 200 mg PO qd  30 d
Oxycodone 5 mg as needed
Total hip replacement
Acetaminophen 975 mg PO q 4 as needed
Oxycodone 5 mg as needed
Lyrica 50 mg PO bid  14 dc
PO, per oral.
a Unless contraindicated.
b Not given if periarticular injection included Toradol 15 cc.
c In select patients with breakthrough pain.
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anesthesia. The use of femoral nerve blocks for TKRs was dis-
continued. Patient-controlled anesthesia was discontinued. Day of
surgery mobilization was attempted in almost all patients. Acet-
aminophen (975 mg) was added to the postoperative analgesic
medication list.Study design
Institutional review board approval was obtained. A prospec-
tively maintained institutional Joint Outcomes database was
queried for all primary total hip and knee replacements. All pro-
cedures were performed by 2 surgeons from April 2014 to March
2015. The 2 surgical techniques used for THRs were the direct
anterior and posterior-lateral approach. There was no criterion for
assigning patients to a particular surgical technique. It was deter-
mined using patient and surgeon preference. All TKRs were per-
formed via a standard medial patellar arthrotomy. The new 1-day
LOS protocol was introduced on April 1, 2014. The aim of this study
was to evaluate the impact of an earlier (1-day LOS) discharge on
readmissions.
A total of 655 TJRs met our initial criteria, of which 196 were
discharged to rehabilitation and excluded. This exclusion criterion
was based on Medicare’s requirement for a minimum 3-day inpa-
tient stay for patients to go to a skilled nursing facility. This left a
total of 459 (70%) TJRs in this study. Patients were then categorized
into the 1-day or 2-day LOS groups. Length of hospital stay was
determined by medical clearance and the ability to safely ambulate
after surgery.
Patient demographics of age, gender, body mass index (BMI),
and comorbidity were recorded. Table 2 summarizes the patient
demographics for patients discharged to rehabilitation facilities
that were excluded (LOS 3 days) from this study. The primary end
points were our readmissions rate, which were assessed using
CMS’s TJR-speciﬁc quality measures [19]. Secondary end points
examined variables associated with early discharge.
CMS TJR-speciﬁc quality measures: patients were evaluated for
a total of 8 postoperative complications [19]. Patients presenting
with an acute myocardial infarct, pneumonia, or sepsis/septicemia/
shock during the index of admission or within 7 days of admissionTable 2
Patient demographics for patients excluded from study.
Demographics LOS 3 d
N 196
Age (y) 70.4
Body mass index (kg/m2) 31.2
Gender
Male 28.6%
Female 71.4%
Comorbidity
Diabetes 25.0%
Hypertension 74.0%
Hyperlipidemia 57.7%
Gastroesophageal reﬂux disease 42.3%
Coronary artery disease 12.2%
Chronic obstructive pulmonary disease 11.7%
Congestive heart failure 4.6%
Liver cirrhosis 0.5%
Atrial ﬁbrillation 14.3%
Pacemakers 1.5%
Past medical history
History of DVT/PE 5.6%
History of CVA/TIA 8.2%
History of myocardial infarct 4.1%
CVA, cerebrovascular accident; DVT, deep vein thrombosis; PE, pulmonary embo-
lism; TIA, transient ischemic attack.
ay increase readmissions after total joint replacements?, Arthroplasty
Table 3
Patient demographics (n ¼ 459).
Demographics 1-day LOS 2-day LOS P value
N 174 285
Age (y) 61.7 ± 8.6 64.8 ± 8.6 <.001
Body mass index (kg/m2) 30.0 ± 5.8 31.4 ± 6.0 .012
Gender .001
Male 98 (56.3%) 115 (40.4%)
Female 76 (43.7%) 170 (59.6%)
Comorbidity
Diabetes 18 (10.3%) 38 (13.3%) .343
Hypertension 96 (55.2%) 193 (67.7%) .007
Hyperlipidemia 87 (50.0%) 160 (56.1%) .200
Gastroesophageal reﬂux disease 45 (25.9%) 84 (29.5%) .404
Coronary artery disease 12 (6.9%) 37 (13.0%) .041
Chronic obstructive pulmonary disease 6 (3.4%) 14 (4.9%) .456
Congestive heart failure 1 (0.6%) 3 (1.1%) .593
Liver cirrhosis 1 (0.6%) 2 (0.7%) .870
Atrial ﬁbrillation 12 (6.9%) 27 (9.5%) .337
Pacemakers d 5 (1.8%) .079
Past medical history
History of DVT/PE 4 (2.3%) 18 (6.3%) .051
History of CVA/TIA 5 (2.9%) 16 (5.6%) .173
History of myocardial infarct 4 (2.3%) 15 (5.3%) .122
The bold signiﬁes P values that meet statistical signiﬁcance.
CVA, cerebrovascular accident; DVT, deep vein thrombosis; PE, pulmonary embo-
lism; TIA, transient ischemic attack.
Table 5
Perioperative data.
Variable 1-day LOS 2-day LOS P value
Anesthesia type .001
General 94 (54.0%) 196 (68.8%)
Spinal 80 (46.0%) 89 (31.2%)
Anterior approach to THA 73 (83.0%) 76 (65.0%) .004
Skin-to-skin operating time (min) 79.7 ± 14.9 85.6 ± 23.5 .001
Estimated blood loss (mL) 234.0 ± 158.3 264.8 ± 215.5 .104
Preoperative hematocrit 41.8 ± 3.4 41.4 ± 3.7 .217
PACU hematocrit 37.3 ± 3.9 36.3 ± 3.8 .213
POD 1 hematocrit 33.6 ± 3.9 33.3 ± 3.7 .364
Preoperative hemoglobin 14.1 ± 1.3 13.9 ± 1.3 .143
POD 1 hemoglobin 11.0 ± 1.1 11.3 ± 1.3 .303
The bold signiﬁes P values that meet statistical signiﬁcance.
PACU, postoperative acute care unit; THA, total hip arthroplasty.
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deaths were recorded within the 30-day postoperative period.
Mechanical complications and periprosthetic joint and wound in-
fections were assessed up to 90 days postoperatively.
Statistical analysis
The Pearson’s chi-square test was used to analyze categorical
variables, such as gender, comorbidity, and incidence of read-
missions, between the 1- vs 2-day LOS groups. Two-sided Fisher’s
exact test was used for categorical variables that did not achieve
sufﬁcient power for chi-square analysis, deﬁned as when a cell had
an expected frequency of 5 or less. Oneway analysis of variancewas
used for continuous variables, such as age, BMI, surgical time, and
blood loss. All analyses were performed using IBM SPSS Statistics
version 23 (Armonk, NY). A P value less than or equal to .05 was
treated as statistically signiﬁcant.
Results
A total of 459 TJRs were included in this study. The 1-day group
(n¼ 174) comprised 86 TKRs and 88 THRs, whereas the 2-day group
(n ¼ 285) comprised 168 TKRs and 117 THRs. Patients in the 1-day
group were more likely to be younger (61.7 vs 64.8 years, P < .001),
be male (56.3% vs 40.4%, P ¼ .001), and have a lower BMI (30.0 vs
31.4 kg/m2, P ¼ .012) status compared to the 2-day group (Table 3).Table 4
Preoperative risk.
Variable 1-day LOS (%) 2-day LOS (%) P value
ASA score .115
1 4.0 1.8
2 71.3 64.4
3 23.6 31.7
4 1.1 2.1
Number of comorbidity .146
None 17.8 11.2
1 28.2 25.6
2 28.7 25.3
3 16.1 20.0
4 9.2 17.9
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hypertension (P ¼ .007), coronary artery disease (P ¼ .041), and
deep vein thrombosis/pulmonary embolisms (P ¼ .051). The overall
number of comorbidity (P ¼ .146) or American Society of Anes-
thesiologists (ASA) score (P ¼ .115) did not differ between groups
(Table 4).
Patients in the 1-day group more often had spinal anesthesia
(46.0 % vs 31.2%, P ¼ .001), THRs via the direct anterior approach
(83.0% vs 65.0%, P ¼ .004), and shorter surgical times (79.7 vs 85.6
minutes, P ¼ .001). Intraoperative blood loss and postoperative
hematocrit or hemoglobin levels did not differ between groups
(Table 5).
No patients presented with an acute myocardial infarct, pneu-
monia, or sepsis episode within 7 days of surgery (Table 6). No
surgical site bleeds or deaths were noted in the 30-day post-
operative period. The incidence of pulmonary embolisms did not
differ between groups (P ¼ .434). The 90-day readmissions rate for
wound-related complications were similar for patients in the 1-
and 2-day LOS cohorts (1.1% vs 1.1%, P¼ .617). Two patients in the 1-
day LOS group were readmitted for wounds infections within 90
days of surgery. One required 2 debridement procedures whereas
the other was managed medically. Of the 3 patients readmitted
within 90 days of surgery in the 2-day LOS group, one patient
required manipulation under anesthesia for stiffness, one required
debridement for a wound infection, and another presented with a
methicillin-resistant Staphylococcal prosthetic joint infection that
required 2 surgical procedures.
The overall all-cause 30-day readmissions rate did not differ for
patients in the 1- and 2-day LOS groups (2.3% vs 2.5%, P ¼ .591).
Four patients in the 1-day LOS cohort had 5 readmission events
within 30 days of surgery. Two patients presented with the previ-
ously described wound-related complications, one was readmitted
for hyperglycemia and another for syncope secondary to ortho-
static hypotension. The latter 2 patients were managed conserva-
tively. In the 2-day cohort, 7 patients were readmitted within 30
days of surgery. In addition to the previously described prosthetic
join infection, the other causes for readmission in this subgroup
were postoperative ileus (n ¼ 2), pulmonary embolism, upperTable 6
Postoperative complications.
Readmissions 1-day LOS 2-day LOS P value
7-day readmissions (0) 0% (0) 0% e
30-day readmissions (0) 0% 1 (0.4%) .434
Pulmonary embolism d 1
90-day readmissions 2 (1.1%) 3 (1.1%) .617
Prosthetic joint infections d 1
Wound infections 2 2
30-day all-cause readmissions 4 (2.3%) 7 (2.5%) .591
y increase readmissions after total joint replacements?, Arthroplasty
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ﬁbrillation. All were managed medically.
Discussion
ERAS pathways lower postoperative morbidity and mortality
using multimodal interventions aimed at decreasing stress-
induced organ dysfunction [23]. Speciﬁcally in TJR surgery, ERAS
decreases the need for blood transfusions [12,16], decreases returns
to the operating room [12], and reduces 30- and 90-day mortality
[12,13,15,17]. Emphasizing an early discharge, these programs help
attenuate costs associated with TJRs [24e27] without corre-
spondingly increasing complications or readmissions [12e17].
Our study demonstrates that you can promote a 1-day LOS
discharge protocol to patients undergoing TJRs, without adversely
impacting outcomes. We observed no increase in early complica-
tions or readmissions between the 1- and 2-day LOS patients in our
updated ERAS program. Our ﬁndings are consistent with other
studies [7,14]. Stambough et al. [14] conducted a retrospective re-
view of 1751 primary THRs and observed a 52% reduction in LOS
after the implementation of an ERAS pathway. The study reported
no subsequent increase in the overall 30-day readmissions rate.
Similarly, Husted et al. [7] decreased average LOS by 3.2 days
without correspondingly increasing readmissions.
Prior investigations have explored the reasons for readmissions
after TJRs [28e30]. Our ﬁndings are consistent with these reports,
with infection- and procedure-related complications being themost
common reasons for readmission. Studies have also reported risk
factors correlatingwith readmissions after TJRs [28,31e33]. Saucedo
et al. [28] found that age <50 or >80 years, BMI <18.5 or 30, dia-
betes, coronary artery disease, and hospital stays 5 days increased
the risk for readmissions [28]. Bini et al. [34] report that patients
discharged to a skilled nursing facility were more likely to be read-
mitted vs those discharged tohome; however, Tayne et al. [35] found
no correlation between discharge disposition and readmissions.
Instead, Tayne et al. found that female gender, ASA class 3 or 4, and
longer operative times correlated with increased readmissions.
There are limitations to our study. Two high volume surgeons at
a single institute were included in this retrospective review, which
may have impacted the results of our study. Studies have demon-
strated that high volume surgeons have fewer readmissions,
shorter LOS, and more discharges to home [36,37]. Another limi-
tation in our study was that, although we performed a detailed
chart review and history at each postoperative visit, is it possible
that some readmissions to other institutions may not have been
discovered. We did elicit one readmission episode to an outside
facility from the patient chart and included it in our analysis.
In addition to evaluating our readmissions rate after early
discharge, our study looked to identify variables that could help us
identify patients more likely to discharge on postoperative day
(POD) 1. Our study found certain patient characteristics to be
associatedwith patients in the 2-day LOS cohort. Older patients and
patients with a higher BMI were associated with a longer hospital
stay, which is consistent with other studies [6,20e22,38,39]. A
preexisting diagnosis of hypertension also correlated with longer
stays. Studies have demonstrated female gender to be predictive of
LOS [6,39,40]. Consistent with these ﬁndings, we observed female
gender to be associated with patients in the 2-day LOS cohort. This
may be because women are more likely to present for surgery later
in life, with greater physical dysfunction [41,42]. Studies have also
demonstrated an association between ASA score and LOS [6,38].We
could not corroborate these ﬁndings. This is likely due to differ-
ences in inclusion criteria between our studies. Husted et al. [6]
reviewed a consecutive series of unselected patients, whereas our
study reviewed a consecutive series of patients that werePlease cite this article in press as: U.S. Sibia, et al., Do shorter lengths of st
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bilitation, who tend to present with greater comorbidity (Table 1),
were excluded from our analysis.
Literature has shown that pain, dizziness, and weakness were
the cause for most (80% of patients) longer hospital stays [43].
Intensive postoperative multimodal nonopioid pain management
[44], prevention of orthostatic hypertension [45], and early phys-
iotherapy [46] help reduce postoperative pain, dizziness, and
muscle weakness, respectively. Husted et al. also observed that 3%
of their study patients felt insecure with an early discharge. Pre-
operative patient education and postoperative reassurance can
help comfort this subset of patients. Organizational factors (waiting
for physiotherapy or postoperative radiographs) accounted for the
remainder of delays (20% of patients) in their study.
Conclusions
Enhanced recovery after surgery pathways can be updated to
shorten length of stay, without adversely impacting postoperative
complications or readmissions. Shorter lengths of stay may help
attenuate costs associated with total joint replacements. Further
study and reﬁnement of enhanced recovery after surgery protocols
may allow more patients to be safely discharged on postoperative
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